Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Trading

Pound licks wounds as Haldane exit signals dovish tilt

Sterling weathers vaccine issues, climbs for second day

By Ritvik Carvalho and Saikat Chatterjee

LONDON (Reuters) -The British pound held near a two-month low against the dollar and nursed losses against the euro on Tuesday after the Bank of England said its chief economist will leave the central bank later this year.

While the reaction in currency markets was muted, with the pound holding close to the day’s lows against its main rivals, Haldane’s exit is widely seen as a departure of one of the more hawkish figures at the central bank.

Haldane has been the most upbeat member of the BoE’s Monetary Policy Committee on prospects for a sharp economic recovery from the COVID-19 pandemic and in February likened inflation to a tiger that could easily be roused.

Against the dollar, the British currency was down 0.1% at $1.3692, having touched its lowest since Feb. 5 at $1.3670 in the previous session.

“I think Haldane being considered a hawk in the MPC camp is the reason why the pound has struggled today,” said TF Global Markets analyst Fawad Razaqzada.

“People bullish on the pound are not taking any chances, as he could be replaced by a dovish policymaker.”

Against the euro, the pound held below the day’s lows at 86.87 pence. It hit a more than six-week low of 87.12 pence earlier, Refinitiv data shows.

“For sterling, given Haldane’s hawkish stance, his resignation offers only downside potential,” said Stuart Cole, chief macro strategist at London-based Equiti Capital.

Money market futures were broadly unchanged on the news, with interest rate futures expecting the Bank of England to keep rates unchanged until mid-2022.

Britain has offered all over-50s a first dose of COVID-19 vaccine as the rollout of Moderna’s shot in England began on Tuesday, the government said, adding that it was on track to give a shot to all adults by the end of July.

Sterling has been among the best-performing G10 currencies this year, enjoying its strongest quarter against the euro since 2015. The pace of Britain’s vaccination drive has led analysts to bet on a quick economic rebound from the country’s worst contraction in 300 years.

The pound lost 1% against the dollar last week as Britain proposed to use alternatives to the Oxford-AstraZeneca COVID-19 vaccine to inoculate people aged under 30. Britain has largely depended on the AstraZeneca vaccine to vaccinate more than half of its population.

(Reporting by Ritvik CarvalhoEditing by Larry King and David Goodman)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post